p120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling.

p120-RasGAP (Ras GTPase activating protein) plays a key role in the regulation of Ras-GTP bound by promoting GTP hydrolysis via its C-terminal catalytic domain. The p120-RasGAP N-terminal part contains two SH2, SH3, PH (pleckstrin homology) and CaLB/C2 (calcium-dependent phospholipid-binding domain) domains. These protein domains allow various functions, such as anti-/pro-apoptosis, proliferation and also cell migration depending of their distinct partners. The p120-RasGAP domain participates in protein-protein interactions with Akt, Aurora or RhoGAP to regulate functions described bellow. Here, we summarize, in angiogenesis and cancer, the various functional roles played by p120-RasGAP domains and their effector partners in downstream signaling.

[1]  C. Schneider,et al.  The Calpain System as a Modulator of Stress/Damage Response , 2007, Cell cycle.

[2]  M. Bickle,et al.  A RasGAP SH3 Peptide Aptamer Inhibits RasGAP-Aurora Interaction and Induces Caspase-Independent Tumor Cell Death , 2008, PloS one.

[3]  C. Prigent,et al.  Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. , 1999, Journal of cell science.

[4]  D. Lowy,et al.  Function and regulation of ras. , 1993, Annual review of biochemistry.

[5]  J. Settleman,et al.  GAP control: regulating the regulators of small GTPases. , 2004, Trends in cell biology.

[6]  A. Huttenlocher,et al.  Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. , 2002, Journal of cell science.

[7]  Zhong-ying Shen,et al.  Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers , 2007, Proceedings of the National Academy of Sciences.

[8]  F. Clerc,et al.  Identification of the SH3 domain of GAP as an essential sequence for Ras-GAP-mediated signaling. , 1993, Science.

[9]  L. J. Veer,et al.  N-ras mutations in human cutaneous melanoma from sun-exposed body sites , 1989, Molecular and cellular biology.

[10]  R. Huganir,et al.  SynGAP: a Synaptic RasGAP that Associates with the PSD-95/SAP90 Protein Family , 1998, Neuron.

[11]  G. Rosen,et al.  Proteolytic cleavage of Ras GTPase-activating protein during apoptosis , 1998, Cell Death and Differentiation.

[12]  A. El'skaya,et al.  A2 isoform of mammalian translation factor eEF1A displays increased tyrosine phosphorylation and ability to interact with different signalling molecules , 2008, International Journal of Biochemistry and Cell Biology.

[13]  B. Vogelstein,et al.  Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.

[14]  B. Ponder,et al.  Oncogenes and bladder cancer. , 1985, British journal of urology.

[15]  H. Langen,et al.  IκBα and IκBα/NF-κB Complexes Are Retained in the Cytoplasm through Interaction with a Novel Partner, RasGAP SH3-binding Protein 2* , 2000, The Journal of Biological Chemistry.

[16]  C. Widmann,et al.  Caspase-dependent Cleavage of Signaling Proteins during Apoptosis , 1998, The Journal of Biological Chemistry.

[17]  M. Boguski,et al.  cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. , 1991, Genomics.

[18]  Michel Vidal,et al.  Capns1, a new binding partner of RasGAP-SH3 domain in K-Ras(V12) oncogenic cells: modulation of cell survival and migration. , 2008, Cellular signalling.

[19]  C. Enrich,et al.  Molecular mechanisms involved in Ras inactivation: the annexin A6–p120GAP complex , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  D. Bar-Sagi,et al.  Ras effectors and their role in mitogenesis and oncogenesis , 1997, Journal of Molecular Medicine.

[21]  P. Cullen,et al.  CAPRI regulates Ca2+-dependent inactivation of the Ras-MAPK pathway , 2001, Current Biology.

[22]  D. Michod,et al.  Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light. , 2007, Journal of photochemistry and photobiology. B, Biology.

[23]  Mark S. Boguski,et al.  Proteins regulating Ras and its relatives , 1993, Nature.

[24]  M. Moran,et al.  Phosphorylation-dependent complexes of p120 Ras-specific GTPase-activating protein with p62 and p190. , 1995, Methods in enzymology.

[25]  T. Pawson,et al.  Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap , 1997, Molecular and cellular biology.

[26]  M. Rebecchi,et al.  Pleckstrin homology domains: a common fold with diverse functions. , 1998, Annual review of biophysics and biomolecular structure.

[27]  Peter J. Cullen,et al.  Identification of a specific lns(l,3,4,5)P4-binding protein as a member of the GAP1 family , 1995, Nature.

[28]  A. Gratwohl,et al.  Mutation analysis of the N‐ras proto‐oncogene in active and remission phase of human acute leukemias , 1988, International journal of cancer.

[29]  G. A. Martin,et al.  Molecular cloning of two types of GAP complementary DNA from human placenta. , 1988, Science.

[30]  P. Hordijk,et al.  Targeting and localized signalling by small GTPases , 2007, Biology of the cell.

[31]  B. Tocqué,et al.  Ras-GAP Controls Rho-Mediated Cytoskeletal Reorganization through Its SH3 Domain , 1998, Molecular and Cellular Biology.

[32]  S. Hanks,et al.  Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells , 2004, Oncogene.

[33]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.

[34]  Y. Imai,et al.  A novel mammalian Ras GTPase-activating protein which has phospholipid-binding and Btk homology regions , 1994, Molecular and cellular biology.

[35]  Giulio Draetta,et al.  Ras–GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease , 2001, Oncogene.

[36]  G. Waeber,et al.  Expression of an Uncleavable N-terminal RasGAP Fragment in Insulin-secreting Cells Increases Their Resistance toward Apoptotic Stimuli without Affecting Their Glucose-induced Insulin Secretion* , 2005, Journal of Biological Chemistry.

[37]  J. Johnston,et al.  Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras , 2001, Nature Cell Biology.

[38]  M. Moran,et al.  CaLB: a 43 amino acid calcium-dependent membrane/phospholipid binding domain in p120 Ras GTPase-activating protein. , 1995, Oncogene.

[39]  T. Pawson,et al.  Transgenic RNA interference in ES cell–derived embryos recapitulates a genetic null phenotype , 2003, Nature Biotechnology.

[40]  A. Warshel,et al.  Why does the Ras switch “break” by oncogenic mutations? , 2004, Proteins.

[41]  Seamus J. Martin,et al.  Partial Cleavage of RasGAP by Caspases Is Required for Cell Survival in Mild Stress Conditions , 2004, Molecular and Cellular Biology.

[42]  K. Chébli,et al.  A Novel Phosphorylation-Dependent RNase Activity of GAP-SH3 Binding Protein: a Potential Link between Signal Transduction and RNA Stability , 1998, Molecular and Cellular Biology.

[43]  M. Moran,et al.  Regulation of extracellular signal-regulated kinase activity by p120 RasGAP does not involve its pleckstrin homology or calcium-dependent lipid binding domains but does require these domains to regulate cell proliferation. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[44]  G. Jianren,et al.  Oncogenes in human primary hepatic cancer , 1986 .

[45]  T. Gilmer,et al.  The Ras/p120 GTPase-activating Protein (GAP) Interaction Is Regulated by the p120 GAP Pleckstrin Homology Domain* , 2000, The Journal of Biological Chemistry.

[46]  B. Tocqué,et al.  Ras-GTPase activating protein (GAP): a putative effector for Ras. , 1997, Cellular signalling.

[47]  P. Pandolfi,et al.  Role of Dok-1 and Dok-2 in Leukemia Suppression , 2004, The Journal of experimental medicine.

[48]  R. Jove,et al.  Two SH2 Domains of p120 Ras GTPase-activating Protein Bind Synergistically to Tyrosine Phosphorylated p190 Rho GTPase-activating Protein (*) , 1995, The Journal of Biological Chemistry.

[49]  G. Fleuren,et al.  KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. , 1988, Nucleic acids research.

[50]  C. Marshall,et al.  MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. , 1994, Current opinion in genetics & development.

[51]  E. Hafen,et al.  Control of Growth and Differentiation byDrosophila RasGAP, a Homolog of p120 Ras–GTPase-Activating Protein , 1999, Molecular and Cellular Biology.

[52]  J. Rhim,et al.  Activated H-ras oncogenes in human kidney tumors. , 1988, Cancer research.

[53]  L. Parada,et al.  Tumor microenvironment and neurofibromatosis type I: connecting the GAPs , 2007, Oncogene.

[54]  M. Lemmon.  Pleckstrin Homology Domains: Two Halves Make a Hole? , 2005, Cell.

[55]  M. Santoro,et al.  A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases , 1987, Nature.

[56]  G. Babcock,et al.  Oncogenic RAS Induces Accelerated Transition through G2/M and Promotes Defects in the G2 DNA Damage and Mitotic Spindle Checkpoints* , 2006, Journal of Biological Chemistry.

[57]  J. Camonis,et al.  Identification of Aurora Kinases as RasGAP Src Homology 3 Domain-binding Proteins* , 2002, The Journal of Biological Chemistry.

[58]  S. Moss,et al.  The Ca2+-dependent lipid binding domain of P120GAP mediates protein-protein interactions with Ca2+-dependent membrane-binding proteins. Evidence for a direct interaction between annexin VI and P120GAP. , 1996, The Journal of biological chemistry.

[59]  Y. Cheng,et al.  Oncogenes in human primary hepatic cancer , 1986, Journal of cellular physiology. Supplement.

[60]  T Pawson,et al.  Src homology region 2 domains direct protein-protein interactions in signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Gideon Bollag,et al.  GTPase activating proteins: critical regulators of intracellular signaling. , 2002, Biochimica et biophysica acta.

[62]  H. Langen,et al.  IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2. , 2000, The Journal of biological chemistry.

[63]  N. Sherman,et al.  Phosphotyrosine (p-Tyr)-Dependent and -Independent Mechanisms of p190 RhoGAP-p120 RasGAP Interaction: Tyr 1105 of p190, a Substrate for c-Src, Is the Sole p-Tyr Mediator of Complex Formation , 1998, Molecular and Cellular Biology.

[64]  C. Widmann,et al.  The RasGAP N-terminal Fragment Generated by Caspase Cleavage Protects Cells in a Ras/PI3K/Akt-dependent Manner That Does Not Rely on NFκB Activation* , 2002, The Journal of Biological Chemistry.

[65]  F. McCormick,et al.  RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. , 1988, Leukemia.

[66]  K. Cailliau,et al.  RasGAP is involved in signal transduction triggered by FGF1 in Xenopus oocytes expressing FGFR1 , 2001, FEBS letters.

[67]  Yi Zheng,et al.  p200 RhoGAP Promotes Cell Proliferation by Mediating Cross-talk between Ras and Rho Signaling Pathways* , 2007, Journal of Biological Chemistry.

[68]  J. Settleman,et al.  Tandem SH2 binding sites mediate the RasGAP–RhoGAP interaction: a conformational mechanism for SH3 domain regulation , 1997, The EMBO journal.

[69]  J. Thompson,et al.  The PH domain: a common piece in the structural patchwork of signalling proteins. , 1993, Trends in biochemical sciences.

[70]  N. Mitin,et al.  RAS and the RAIN/RasIP1 effector. , 2006, Methods in enzymology.

[71]  Miikka Vikkula,et al.  Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. , 2003, American journal of human genetics.

[72]  C. Der,et al.  The Ras branch of small GTPases: Ras family members don't fall far from the tree. , 2000, Current opinion in cell biology.

[73]  B. Tocqué,et al.  Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells , 1999, Oncogene.

[74]  J. Mulliken,et al.  RASA1: variable phenotype with capillary and arteriovenous malformations. , 2005, Current opinion in genetics & development.

[75]  K. Lim,et al.  Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance. , 2005, Cancer cell.

[76]  D. Stephenson,et al.  Recent developments in neurofibromatosis type 1 , 2007, Current opinion in neurology.

[77]  Brian Schryver,et al.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.

[78]  J. Abecassis,et al.  G3BP is overexpressed in human tumors and promotes S phase entry. , 2001, Cancer letters.

[79]  P. Lapinski,et al.  Generation of mice with a conditional allele of the p120 Ras GTPase‐activating protein , 2007, Genesis.

[80]  C. Widmann,et al.  Antiapoptotic Signaling Generated by Caspase-Induced Cleavage of RasGAP , 2001, Molecular and Cellular Biology.

[81]  M. Abdellatif,et al.  Ras GTPase-activating Protein Binds to Akt and Is Required for Its Activation* , 2004, Journal of Biological Chemistry.

[82]  E. E. Gresch.  Genetic Alterations During Colorectal-Tumor Development , 1989 .

[83]  M. Moran,et al.  Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPase-activating protein , 1991, Molecular and cellular biology.

[84]  Jingwu Xie,et al.  Oncogenic KRAS Activates Hedgehog Signaling Pathway in Pancreatic Cancer Cells* , 2007, Journal of Biological Chemistry.

[85]  C. Widmann,et al.  High resolution crystal structures of the p120 RasGAP SH3 domain. , 2007, Biochemical and biophysical research communications.

[86]  J. D. Clark,et al.  A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP , 1991, Cell.

[87]  A. Bernards.  GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. , 2003, Biochimica et biophysica acta.

[88]  P. Pandolfi,et al.  Molecular Cloning and Characterization of p56 dok-2 Defines a New Family of RasGAP-binding Proteins* , 1998, The Journal of Biological Chemistry.

[89]  W. Kabsch,et al.  The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. , 1997, Science.

[90]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[91]  T. Pawson,et al.  Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein , 1995, Nature.

[92]  R. Saiki,et al.  Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[93]  T. Pawson,et al.  Role of P120 Ras-Gap in Directed Cell Movement , 2000, The Journal of cell biology.

[94]  E. Winter,et al.  The c-K-ras gene and human cancer (review). , 1987, Anticancer research.

[95]  M. Moran,et al.  Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases , 1990, Nature.

[96]  D. Michod,et al.  TAT-RasGAP317-326 Requires p53 and PUMA to Sensitize Tumor Cells to Genotoxins , 2007, Molecular Cancer Research.

[97]  R. Dixon,et al.  A C‐terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity. , 1989, The EMBO journal.

[98]  Frank McCormick,et al.  ras GTPase activating protein: Signal transmitter and signal terminator , 1989, Cell.

[99]  S. Moss,et al.  Annexins: linking Ca2+ signalling to membrane dynamics , 2005, Nature Reviews Molecular Cell Biology.

[100]  J. Bos,et al.  Activated ras genes in human seminoma: evidence for tumor heterogeneity. , 1989, Oncogene.

[101]  A. Chow,et al.  Identification of a novel protein complex containing annexin VI, Fyn, Pyk2, and the p120GAP C2 domain , 2000, FEBS letters.

[102]  Visvanathan Kv,et al.  Preferential and novel activation of H-ras in human bladder carcinomas. , 1988 .

[103]  S. Moss,et al.  Annexins: from structure to function. , 2002, Physiological reviews.

[104]  L. Debussche,et al.  A Ras-GTPase-activating protein SH3-domain-binding protein , 1996, Molecular and cellular biology.

[105]  S. Rodenhuis,et al.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.

[106]  E. Lees,et al.  The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation , 2000, Oncogene.

[107]  A. Warshel,et al.  How does GAP catalyze the GTPase reaction of Ras? A computer simulation study. , 2000, Biochemistry.